Skip to content

A Comparative Clinical Study to Evaluate the Efficacy of Gudanagaradi Gutika and Phalatrikadi Kwatha in the Management of Pandu Roga (Iron Deficiency Anaemia)

An Open Labelled Parallel Comparative Clinical Study to evaluate the efficacy of Gudanagaradi Gutika and Phalatrikadi Kwatha in the Management of Pandu Roga with Special Reference to Iron Deficiency Anaemia - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071147
Enrollment
60
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

Institute For Ayurved Studies and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to sign the consent form. 2. All patients of age group (25-45years) irrespective of any sex, community and locality will be included. 3. Patients fulfilling the diagnostic criteria for Pandu Roga. 4. Iron Deficiency Anemia (IDA) of mild and moderate types (Hb% within the range of 8- 11gm/dl) will be included.

Exclusion criteria

Exclusion criteria: 1. Patient not willing for clinical trials 2. Patient below age 25 and above age 45 years. 3. Anemia other than IDA will be excluded. 4. Patients of acute blood loss will be excluded. 5. Anemia due to Leukemia & other malignant disorders will be excluded. 6. Hb% below range of 8gm/dl. 7. Patients with history of other systemic diseases such as Diabetes mellitus, CAD, CKD,AKD and endocrinal disorder. 8. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Gudanagaradi gutika in comparison to Phaltrikadi kwath by applying appropriate statistical tools in the management of pandu roga with special reference to iron deficiency anemiaTimepoint: 28 days

Secondary

MeasureTime frame
1. Increase in Hb% 2. Improvement in sign and symptoms of disease 3. Improvement in other biological parameters, general health conditions and quality of lifeTimepoint: 56 day

Countries

India

Contacts

Public ContactDr Pooja

Institute For Ayurved Studies and Research

mehranilam@gmail.com9671368058

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026